TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2018 Financial Results

Go back to TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2018 Financial Results

TG Therapeutics (TGTX) Reports Q3 Loss of $0.43

November 9, 2018 7:35 AM EST

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.43), versus ($0.48) reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

... More